SUMMARY The influence of urinary malignant cell cytology screening has been explored in an industrial population. Survival was prolonged in the screened group partly because a greater proportion of early stage disease was being diagnosed, and partly because of other differences in the screened group which have yet to be defined.
Screening of the urine of workers exposed to the hazard of occupational tumours of the urinary tract has been carried out in the United Kingdom since 1952. A modification of the technique used by Papanicolaoul in 1945 for early detection of cancer of the cervix is used.2 3 The test is extremely accurate when carried out by a well-trained cytologist.
Malignant cell cytology (MCC) enables tumours to be diagnosed presymptomatically. The purpose of the investigation, of which this is a preliminary report was to determine whether:
(1) Tumours diagnosed by MCC are at an earlier pathological stage of development than those found after the development of symptoms.
(2) Diagnosis by MCC and consequently earlier treatment results in a higher rate of cure, or longer survival.
Methods
All The Xs test contrasted the factory screened with the unscreened group by amalgamating types T2, T3, and T4 to contrast with Ti.
When survival was computed by the log-rank method to include all causes of death it could be shown that the overall survival of a worker at the factory (diagnosed by either means) and a hospital case did not differ (X2 overall=0-06, df= 1, p=0-8l.).
Each group had a 50% survival at seven years, a 40% survival at 10 years, and a 25% survival at 15 years. Differences were seen, however, when the mode of diagnosis of the factory series was taken into account. The group diagnosed by MCC survived longer, and those diagnosed symptomatically shorter, than the hospital series. The ratio of observed to expected deaths is shown in Table 2 . When all three groups were contrasted, however, the differences were just not significant at the 5% level, although there were significant differences when the two factory series alone were contrasted (X2=6 1i p=0.01). The survival curve including the hospital series is shown in Fig. 1 . When account was also taken of the stage at diagnosis, the differences between the groups were reduced, as shown in Table 3 , and were no longer statistically significant (p=0 17). However, the same general pattern was found and did not completely disappear: stage at presentation accounted for less than half the differences seen.
The above data all refer to all causes of death. When the data were censored to leave deaths ascribed only to bladder cancer or the immediate complications of its treatment, the major differences between the groups were reduced to non-significant levels (X2=0527 p=0.88). The survival curve is shown in Fig. 2 x' overall = 3-52 2 df p = 0-17
In Table 4 the survival timing of the MCC cases is contrasted with the rest of the factory cases for the uncensored data.
Discussion
A study of this kind is of particular relevance because the Carcinogenic Substances Regulations of 1967, which make it mandatory for urinary malignant cell cytology to be carried out in certain occupations, are under review, and there are some who believe that early diagnosis does not materially improve the prognosis in cases of bladder cancer. This suggests that the factory cases might have had a basically more aggressive disease. It could be postulated that some length bias would have occurred in the screened group with an over-representation of slow-growing lesions and the rapidly aggressive lesions presenting as interval cases.6 This source of bias is unlikely in this particular population, in that once self-selection had occurred in the work force, those who accepted the screening programme did so with great regularity, producing urine specimens once a month, and no interval cases arose in that group; also, cases found at the first screen were eliminated from the analyses.
Some selection bias might have occurred in that the scheme was voluntary and participation in the programme might have been influenced by past exposure. If one accepts that high exposure might lead to a particularly aggressive disease, then thbe screened group might have been expected to fare particularly badly; There is no evidence that this occurred and anecdotal accounts from the factory suggest that compliance with the scheme was random with respect to previous exposure and length of employment anywhere in the factory complex.
The differences in overall survival were reduced when the stage at diagnosis was taken into consideration, supporting the concept that stage differences accounted in part for the improved overall survival of the MCC group. The improved survival time for this uncensored data for the MCC cases versus the rest of the factory cases is shown in Table 4 . Much of the improved survival of the screened group was due to the excess of the stage one cases found by the screening programme. This is a lead time bias. Adjustments for stage in the survival statistics reduced the X2 value from 5*86 to 3'52. There are several other problems with these analyses. Some of the biases are compensated for by the fact that the, urologists were the same in the hospital and the factory and matches have been made for year of treatment. Nevertheless, the mean ages of patients in the two groups, hospital and factory, were not exactly matched and this could have influenced the survivals marginally. The question as to whether or not to use censored or uncensored data is not at first sight clear in this study. Censoring the data means that only bladder cancer deaths are considered in the computations. Some loss of sensitivity occurs when all causes of death are considered, because in 25 years of follow-up many 'natural deaths' due to causes other than bladder cancer will occur. This is balanced and probably outweighed by the bias introduced by the censoring. This bias is due to the inability to separate deaths due to bladder cancer from those arising from other causes. It is likely to be large in this study for a variety of reasons.
The results of censoring show that causes of death other than bladder cancer are proportionately greater in two of the three subsets. This could be fortuitous. The accuracy of death certification is unassessable in this study, spanning many years, and great suspicion can be attached to a number of certificates which attribute the cause of death to lung or brain malignancies without mention of bladder cancer; these could be secondary tumours, for example. Other studies have shown that a significant error can exist.7 There are thus strong arguments for examining only the uncensored results. Both modes of analysis, however, are presented in this report for completeness.
Questions like these are being explored further in an attempt to elucidate what is meant by a 'cure' in these circumstances, and what might be expected from this type of population irrespective of its bladder cancer. The marginal statistical significance of some of these results makes it appropriate to suggest that additional numbers added to the present series would be of great value, although the contrast between the factory cases alone, screened and unscreened, is highly significant.
There has been a tendency to reject many tests of screening, often because clearly defined study populations were not available. There was a fear that this would also be the case with urinary malignant cell cytology. However, our findings indicate that the screened population initially survives longer than the hospital or the rest of the factory population. The differences in survival amount to years, contrasting the MCC group with the unscreened factory group. These results are not just statistically significant when the hospital cases are included. Nevertheless, the trend in all types of survival analysis is for the MCC screened group to survive longer than the other groups and, for this reason, the consistent lead of the screened group is taken to be a real rather than a fortuitous phenomenon. 
